Literature DB >> 17899227

Mediastinal mass mimicking a tumor in a patient with bladder cancer after Bacillus Calmette-Guerin treatment.

A Somoskovi1, C Carlyn, J Dormandy, M Salfinger.   

Abstract

We describe the case of a 78-year-old male with bladder cancer who developed a mediastinal mass after intravesical immunotherapy with live Mycobacterium bovis BCG. The clinical diagnosis was mediastinal tumor suggestive for lymphoma. However, cultures of the biopsy specimens grew an acid-fast organism, which was identified as M. bovis BCG. To the best of our knowledge, this is the first reported case in which a post-instillation BCG infection induced a mediastinal mass that mimicked a tumor in a patient with bladder cancer.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17899227     DOI： 10.1007/s10096-007-0390-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  17 in total

Review 1.  BCG intravesical instillations: recommendations for side-effects management.

Authors:  P Rischmann; F Desgrandchamps; B Malavaud; D K Chopin
Journal:  Eur Urol       Date:  2000       Impact factor: 20.096

2.  Identification of substrains of BCG vaccine using multiplex PCR.

Authors:  J Bedwell; S K Kairo; M A Behr; J A Bygraves
Journal:  Vaccine       Date:  2001-02-28       Impact factor: 3.641

3.  Granulomatous hepatitis: a complication of B.C.G. immunotherapy.

Authors:  J S Hunt; M J Silverstein; F C Sparks; C M Haskell; Y H Pilch; D L Morton
Journal:  Lancet       Date:  1973-10-13       Impact factor: 79.321

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

Review 5.  Bacille Calmette-Guérin in superficial transitional cell carcinoma.

Authors:  N A Mungan; J A Witjes
Journal:  Br J Urol       Date:  1998-08

6.  Molecular confirmation of bacillus Calmette-Guérin as the cause of pulmonary infection following urinary tract instillation.

Authors:  M Kristjansson; P Green; H L Manning; A M Slutsky; S M Brecher; C F von Reyn; R D Arbeit; J N Maslow
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

7.  Detection of bacillus Calmette-Guerin in the blood by the polymerase chain reaction method of treated bladder cancer patients.

Authors:  S Tuncer; M I Tekin; H Ozen; C Bilen; S Unal; D Remzi
Journal:  J Urol       Date:  1997-12       Impact factor: 7.450

8.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

9.  Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer.

Authors:  D L Lamm; V D Stogdill; B J Stogdill; R G Crispen
Journal:  J Urol       Date:  1986-02       Impact factor: 7.450

10.  Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment.

Authors:  D L Paterson; A Patel
Journal:  Aust N Z J Surg       Date:  1998-05
View more
  3 in total

1.  Direct comparison of the genotype MTBC and genomic deletion assays in terms of ability to distinguish between members of the Mycobacterium tuberculosis complex in clinical isolates and in clinical specimens.

Authors:  Akos Somoskovi; Jillian Dormandy; Jeremy Rivenburg; Maria Pedrosa; Melinda McBride; Max Salfinger
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

Review 2.  Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.

Authors:  Betty A Forbes; Geraldine S Hall; Melissa B Miller; Susan M Novak; Marie-Claire Rowlinson; Max Salfinger; Akos Somoskövi; David M Warshauer; Michael L Wilson
Journal:  Clin Microbiol Rev       Date:  2018-01-31       Impact factor: 26.132

Review 3.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.